Home / Products /Genome Editing /KO Cell Lines /B4GALT2 Knockout cell line (HEK293)

B4GALT2 Knockout cell line (HEK293)

Catalog Number: KO02566

Price: Online Inquiry

Specifications KO Solutions KO Cell Line Workflow Handling procedures Downloads Related products

Specifications

Product Information
Product Name B4GALT2 Knockout cell line (HEK293)
specification 1*10^6
Storage and transportation Dry ice preservation/T25 live cell transportation.
Cell morphology Epithelioid, adherent cell
Passage ratio 1:3~1:6
species Human
Gene B4GALT2
Gene ID 8704
Build method Electric rotation method / virus method
Mycoplasma testing Negative
Cultivation system 90%DMEM+10% FBS
Parental Cell Line HEK293
Quality Control Genotype: B4GALT2 Knockout cell line (HEK293) >95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins.
Gene Information
Gene Official Full Name beta-1,4-galactosyltransferase 2provided by HGNC
Also known as B4Gal-T2; B4Gal-T3; beta4Gal-T2
Gene Description This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The enzyme encoded by this gene synthesizes N-acetyllactosamine in glycolipids and glycoproteins. Its substrate specificity is affected by alpha-lactalbumin but it is not expressed in lactating mammary tissue. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]
Expression Ubiquitous expression in brain (RPKM 14.6), fat (RPKM 11.8) and 25 other tissues See more

KO Solutions

We develop gene knockout solutions tailored to customer requirements and the condition of the target gene.

  • Editing Tools

Cas9 Protein

Cas9 mRNA sgRNA

Cas9 Plasmid

Cas9 Virus

A – Exon KO

gRNAs are designed in the introns flanking the exon, targeting non-multiple-of-3 base deletions in the exon, resulting in frameshift mutations.

B - Frameshift KO

gRNAs are designed within the exon, creating non-multiple-of-3 base deletions to induce frameshift mutations.

C - Complete KO

The entire gene coding sequence is deleted, achieving large-scale knockout effects.

KO Cell Line Workflow

KO Strategy Design

CRISPR Plasmid/Lentiviral Vector Construction

Lentiviral Packaging

Cell Transfection/Lentiviral Infection

Drug Selection

Cell Cryopreservation

Quality Control

Sequencing Validation

Monoclonal Cell Line Generation

Pool Efficiency Validation

Handling procedures

Cell Thawing

  • Pre-warm complete culture medium in a 37°C water bath.
  • Thaw the cryovial in a 37°C water bath for 1–2 minutes.
  • Transfer the cryovial to a biosafety cabinet (BSC) and wipe the surface with 70% ethanol.
  • Loosen the cap and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete medium.
  • Centrifuge at 125 × g for 5–7 min at room temperature (RT), then discard the supernatant.
  • Resuspend the cell pellet in 5 mL of complete medium and transfer the suspension into a T25 flask.
  • Incubate the cells at 37°C in a 5% CO₂ incubator.
  • Recommended subculturing ratio: 1:2 to 1:3, reaching confluency in 2–3 days.

Cell Passaging

  • When cell confluence reaches 80–90%, proceed with passaging.
  • Pre-warm complete medium, PBS, and trypsin (0.25% Trypsin-EDTA, Gibco 25200-056) in a 37°C water bath. Once near 37°C, spray the bottles with 75% ethanol and place them in the BSC.
  • Retrieve the culture flask from the incubator, spray with 75% ethanol, and transfer it to the BSC.
  • To avoid dislodging cells, gently rinse the monolayer with PBS along the upper wall of the flask. Discard the PBS after washing (use 2 mL for T25 flasks).
  • Add an appropriate volume of trypsin (1.5 mL for T75, 0.5 mL for T25) and gently tilt the flask to ensure full coverage. Adjust the volume as needed. After 1–2 min, when most cells detach, neutralize digestion by adding an equal volume of complete medium. Gently pipette with a 5 mL serological pipette to ensure complete detachment.
  • Transfer the cell suspension to a 15 mL centrifuge tube and spin at 300 × g for 5 min. Discard the supernatant.
  • Resuspend the pellet in 5 mL of complete medium, adjust the seeding ratio as required, and replenish the flask with fresh medium (13–15 mL for T75, 5 mL for T25). Add 1% penicillin-streptomycin (dual antibiotic).
  • Tighten the cap, gently swirl to mix, and place the flask in a 37°C, 5% CO₂ incubator.

Cell Cryopreservation

  • Prepare cryopreservation medium in advance and pre-chill.
  • Ensure cells meet freezing criteria: healthy morphology, late-log phase growth, and absence of contamination or senescence (verify under a microscope).
  • Digest and centrifuge the cells (refer to the passaging protocol).
  • Resuspend the cell pellet in cryopreservation medium (1 mL per vial), mix thoroughly, and aliquot into cryovials.
  • Place the vials in a freezing container and store at −80°C overnight.
  • For long-term storage, transfer the cryovials to a liquid nitrogen tank.

Downloads

Please note that all services are for research use only. Not intended for any clinical use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.